Harry Boxer
The Technical Trader
Despite a very sharp pullback in the morning, after the strong opening, the stock market indices held support once again, and then a 5-wave rally ensued that took the rest of the session into the close to finish with positive gains today.
Net on the day, the Dow was up 122.10 at 16,912.29, about 50 points off the high and about 150 points off the low. The S&P 500 was up 15.91 to 1995.83, 4 points off the high and 19 points off the low. The Nasdaq 100 was up 26.76 to 4333.46, 9 points off the high and 54 points off the low.
Advance-declines were almost 4 to 1 positive on New York Stock Exchange and 3 to 1 positive on Nasdaq. Up/down volume was 4 1/2 to 1 positive on New York, with total volume of a strong 4.5 billion shares. Nasdaq traded a little over 2 billion shares, and had a 3 to 1 positive volume ratio.
TheTechTrader.com board was mostly green. Priceline.com (PCLN) was up 16.13 to 1291.58, and Amazon.com Inc. (AMZN) up 4.46 to 541.94. However, Google Inc. (GOOG) was down 3.08 to 642.36, Apple Inc. (AAPL) down just 53 cents to 110.78, and Netflix, Inc. (NFLX) also down 23 cents to 108.10.
Tesla Motors, Inc. (TSLA) dropped 9.50 to 231.96.
The biotech stocks led the way with a strong day. Intra-Cellular Therapies, Inc. (ITCI) was up 2.41 to 41.83, Heron Therapeutics, Inc. (HRTX) up 2.30 to 26.07, Juno Therapeutics Inc. (JUNO) up 1.42 to 48.75, and NewLink Genetics Corporation (NLNK) 2.19 to 35.77.
In addition, Amgen Inc. (AMGN) had a big day today, up 6.83 to 148.05, on rumors of a takeover, and Celgene Corporation (CELG) gained 4.79 to 116.98.
Checking the TheTechTrader.com percent-gain leaderboard, Lion Biotechnologies, Inc. (LBIO) gained 80 cents to 6.43, or 14%. Voxeljet AG (VJET) thrust 82 cents to 6.73, or 14%. Tetraphase Pharmaceuticals, Inc. (TTPH) stair-stepped its way up 96 cents to 9.29, or 11.5%, on nearly 2 million shares.
Pacific Biosciences of California, Inc. (PACB) ran 1.43 to 7.80, or 23%, and traded as high as 8.09, on 11 million shares, or more than 1000% more volume than average. SunEdison, Inc. (SUNE) had a really good session, up 1.03 to 9.72, or 12%, on 55 million shares traded.
Cross Country Healthcare, Inc. (CCRN) climbed 1.84 to 14.62, or 14%, on nearly a million shares. Core-Mark Holding Company, Inc. (CORE) advanced 8.53 to 73.30, or 13%, on 1.3 million shares. Aerie Pharmaceuticals, Inc. (AERI) bounced 2.35 to 21.25, or 12%, on 1 million shares.
Among other gainers, Wynn Resorts Ltd. (WYNN) was up 4.14 to 71.99, NantKwest, Inc. (NK) up 1.90 to 13.45, TerraForm Power, Inc. (TERP) 1.89 to 19.77, PTC Therapeutics, Inc. (PTCT) 2.44 to 31.49, and Exxon Mobil Corporation (XOM) 1.31 to 79.20.
Global Payments Inc. (GPN) made its way up 12.83 to 128.20, on strong earnings report.
The Direxion Daily FTSE China Bull 3X ETF (YINN) gained 2.46 to 22.61.
Stepping back and reviewing the hourly chart patterns, the indices gapped up and ran to resistance, rolled over hard and came down sharply, but held support, and came back in a 5-wave advance to close just under the session highs going away.
Let's see how it goes tomorrow.
Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
EUR/USD consolidates weekly gains above 1.1150
EUR/USD moves up and down in a narrow channel slightly above 1.1150 on Friday. In the absence of high-tier macroeconomic data releases, comments from central bank officials and the risk mood could drive the pair's action heading into the weekend.
GBP/USD stabilizes near 1.3300, looks to post strong weekly gains
GBP/USD trades modestly higher on the day near 1.3300, supported by the upbeat UK Retail Sales data for August. The pair remains on track to end the week, which featured Fed and BoE policy decisions, with strong gains.
Gold extends rally to new record-high above $2,610
Gold (XAU/USD) preserves its bullish momentum and trades at a new all-time high above $2,610 on Friday. Heightened expectations that global central banks will follow the Fed in easing policy and slashing rates lift XAU/USD.
Week ahead – SNB to cut again, RBA to stand pat, PCE inflation also on tap
SNB is expected to ease for third time; might cut by 50bps. RBA to hold rates but could turn less hawkish as CPI falls. After inaugural Fed cut, attention turns to PCE inflation.
Bank of Japan set to keep rates on hold after July’s hike shocked markets
The Bank of Japan is expected to keep its short-term interest rate target between 0.15% and 0.25% on Friday, following the conclusion of its two-day monetary policy review. The decision is set to be announced during the early Asian session.
Moneta Markets review 2024: All you need to know
VERIFIED In this review, the FXStreet team provides an independent and thorough analysis based on direct testing and real experiences with Moneta Markets – an excellent broker for novice to intermediate forex traders who want to broaden their knowledge base.